<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">33236288</PMID><DateCompleted><Year>2022</Year><Month>04</Month><Day>01</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>01</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1573-6830</ISSN><JournalIssue CitedMedium="Internet"><Volume>42</Volume><Issue>4</Issue><PubDate><Year>2022</Year><Month>May</Month></PubDate></JournalIssue><Title>Cellular and molecular neurobiology</Title><ISOAbbreviation>Cell Mol Neurobiol</ISOAbbreviation></Journal><ArticleTitle>Nerve Growth Factor is a Potential Treated Target in Tg(SOD1*G93A)1Gur Mice.</ArticleTitle><Pagination><StartPage>1035</StartPage><EndPage>1046</EndPage><MedlinePgn>1035-1046</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10571-020-00993-1</ELocationID><Abstract><AbstractText>Nerve growth factor (NGF) is a protective factor of neural cells; the possible relationship between the NGF and the pathogenesis of amyotrophic lateral sclerosis (ALS) hasn't been completely known. In this study, we observed and analyzed the expression and distribution of NGF, as well as the possible relationship between the NGF expression and distribution and the neural cell death in both SOD1 wild-type (WT) and Tg(SOD1*G93A)1Gur (TG) mice applying the fluorescence immunohistochemistry method. The results showed that the expression and distribution of NGF in the anterior horn (AH), the lateral horn (LH), and the surrounding central canal (CC) significantly increased at the supper early stage of ALS (Pre-onset stage) and the early stage (Onset stage), but the NGF expression and distribution in the AH, the LH, and the surrounding CC significantly reduced at the progression stage. The astrocyte, neuron, and oligodendrocyte produced the NGF and the neural precursor cells (NPCs) produced the NGF. The neural cell death gradually increased accompanying with the reduction of NGF expression and distribution. Our data suggested that the NGF was a protective factor of neural cells, because the neural cells in the AH, the LH, and the surrounding CC produced more NGF at the supper early and early stage of ALS; moreover, the NPCs produced the NGF. It implied that the NGF exerted the protective effect of neural cells, prevented from the neural cell death and aroused the potential of self-repair in the development of ALS.</AbstractText><CopyrightInformation>&#xa9; 2020. Springer Science+Business Media, LLC, part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Zhenzhen</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Neurology, Jiangxi Provincial People's Hospital, Affiliated People's Hospital of Nanchang University, Nanchang, 330006, Jiangxi, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, First Affiliated Hospital of Nanchang University, Nanchang, 330006, Jiangxi, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Jianxiang</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurology, Jiangxi Provincial People's Hospital, Affiliated People's Hospital of Nanchang University, Nanchang, 330006, Jiangxi, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Shengyuan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology, Jiangxi Provincial People's Hospital, Affiliated People's Hospital of Nanchang University, Nanchang, 330006, Jiangxi, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xie</LastName><ForeName>Zunchun</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Neurology, First Affiliated Hospital of Nanchang University, Nanchang, 330006, Jiangxi, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Pei</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Neurology, Jiangxi Provincial People's Hospital, Affiliated People's Hospital of Nanchang University, Nanchang, 330006, Jiangxi, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Shishi</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology, Jiangxi Provincial People's Hospital, Affiliated People's Hospital of Nanchang University, Nanchang, 330006, Jiangxi, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Renshi</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0003-0313-3434</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Jiangxi Provincial People's Hospital, Affiliated People's Hospital of Nanchang University, Nanchang, 330006, Jiangxi, China. xurenshi@ncu.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>30560042, 81160161 and 81360198</GrantID><Agency>National Natural Science Foundation of China</Agency><Country/></Grant><Grant><GrantID>GJJ13198, GJJ170021</GrantID><Agency>Education Department of Jiangxi Province</Agency><Country/></Grant><Grant><GrantID>[2014]-47, 20142BBG70062, 20171BAB215022</GrantID><Agency>Jiangxi Provincial Department of Science and Technology</Agency><Country/></Grant><Grant><GrantID>20181019</GrantID><Agency>Health and Family Planning Commission of Jiangxi province</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>11</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cell Mol Neurobiol</MedlineTA><NlmUniqueID>8200709</NlmUniqueID><ISSNLinking>0272-4340</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>9061-61-4</RegistryNumber><NameOfSubstance UI="D020932">Nerve Growth Factor</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D013482">Superoxide Dismutase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>Cell Mol Neurobiol. 2021 Dec 4;:</RefSource><PMID Version="1">34862948</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020932" MajorTopicYN="N">Nerve Growth Factor</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058953" MajorTopicYN="Y">Neural Stem Cells</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013116" MajorTopicYN="N">Spinal Cord</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013482" MajorTopicYN="N">Superoxide Dismutase</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Nerve growth factor</Keyword><Keyword MajorTopicYN="N">Pathogenesis</Keyword><Keyword MajorTopicYN="N">Spinal cord</Keyword><Keyword MajorTopicYN="N">Tg(SOD1*G93A)1Gur mice</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>6</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>10</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>11</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>11</Month><Day>25</Day><Hour>5</Hour><Minute>49</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33236288</ArticleId><ArticleId IdType="doi">10.1007/s10571-020-00993-1</ArticleId><ArticleId IdType="pii">10.1007/s10571-020-00993-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Aoki M (2012) Hepatocyte growth factor therapy for amyotrophic lateral sclerosis. Brain Nerv 64:245&#x2013;254</Citation></Reference><Reference><Citation>Aquilonius SM, Askmark H, Ebendal T, Gillberg PG (1992) No re-expression of high-affinity nerve growth factor binding sites in spinal motor neurons in amyotrophic lateral sclerosis. Eur Neurol 32:216&#x2013;218. https://doi.org/10.1159/000116825</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000116825</ArticleId><ArticleId IdType="pubmed">1324179</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhandari R, Kuhad A, Kuhad A (2018) Edaravone: a new hope for deadly amyotrophic lateral sclerosis. Drugs Today (Barc) 54:349&#x2013;360. https://doi.org/10.1358/dot.2018.54.6.2828189</Citation><ArticleIdList><ArticleId IdType="doi">10.1358/dot.2018.54.6.2828189</ArticleId></ArticleIdList></Reference><Reference><Citation>Blasco H, Mavel S, Corcia P, Gordon PH (2014) The glutamate hypothesis in ALS: pathophysiology and drug development. Curr Med Chem 21:3551&#x2013;3575. https://doi.org/10.2174/0929867321666140916120118</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/0929867321666140916120118</ArticleId><ArticleId IdType="pubmed">25245510</ArticleId></ArticleIdList></Reference><Reference><Citation>Canu N et al (2017) The intersection of NGF/TrkA signaling and amyloid precursor protein processing in Alzheimer&#x2019;s disease neuropathology. Int J Mol Sci. https://doi.org/10.3390/ijms18061319</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms18061319</ArticleId><ArticleId IdType="pubmed">28632177</ArticleId><ArticleId IdType="pmc">5486140</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen LW, Yung KK, Chan YS, Shum DK, Bolam JP (2008) The proNGF-p75NTR-sortilin signalling complex as new target for the therapeutic treatment of Parkinson&#x2019;s disease. CNS Neurol Disord Drug Targets 7:512&#x2013;523. https://doi.org/10.2174/187152708787122923</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/187152708787122923</ArticleId><ArticleId IdType="pubmed">19128208</ArticleId></ArticleIdList></Reference><Reference><Citation>Chia R, Chi&#xf2; A, Traynor BJ (2018) Novel genes associated with amyotrophic lateral sclerosis: diagnostic and clinical implications. Lancet Neurol 17:94&#x2013;102. https://doi.org/10.1016/S1474-4422(17)30401-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(17)30401-5</ArticleId><ArticleId IdType="pubmed">29154141</ArticleId></ArticleIdList></Reference><Reference><Citation>Chico L et al (2017) Cross-talk between pathogenic mechanisms in neurodegeneration: the role of oxidative stress in Amyotrophic Lateral Sclerosis. Arch Ital Biol 155:131&#x2013;141. https://doi.org/10.12871/00039829201744</Citation><ArticleIdList><ArticleId IdType="doi">10.12871/00039829201744</ArticleId><ArticleId IdType="pubmed">29405030</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung CG, Lee H, Lee SB (2018) Mechanisms of protein toxicity in neurodegenerative diseases. Cell Mol Life Sci 75:3159&#x2013;3180. https://doi.org/10.1007/s00018-018-2854-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-018-2854-4</ArticleId><ArticleId IdType="pubmed">29947927</ArticleId><ArticleId IdType="pmc">6063327</ArticleId></ArticleIdList></Reference><Reference><Citation>Cunha MP et al (2016) Creatine affords protection against glutamate-induced nitrosative and oxidative stress. Neurochem Int 95:4&#x2013;14. https://doi.org/10.1016/j.neuint.2016.01.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuint.2016.01.002</ArticleId><ArticleId IdType="pubmed">26804444</ArticleId></ArticleIdList></Reference><Reference><Citation>Dash RP, Babu RJ, Srinivas NR (2018) Two decades-long journey from riluzole to edaravone: revisiting the clinical pharmacokinetics of the only two amyotrophic lateral sclerosis therapeutics. Clin Pharmacokinet 57:1385&#x2013;1398. https://doi.org/10.1007/s40262-018-0655-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40262-018-0655-4</ArticleId><ArticleId IdType="pubmed">29682695</ArticleId></ArticleIdList></Reference><Reference><Citation>Davies AM (2000) Neurotrophins: more to NGF than just survival. Curr Biol 10:R374&#x2013;R376. https://doi.org/10.1016/s0960-9822(00)00480-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0960-9822(00)00480-2</ArticleId><ArticleId IdType="pubmed">10837216</ArticleId></ArticleIdList></Reference><Reference><Citation>Doble A (1996) The pharmacology and mechanism of action of riluzole. Neurology 47:S233&#x2013;S241. https://doi.org/10.1212/wnl.47.6_suppl_4.233s</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/wnl.47.6_suppl_4.233s</ArticleId><ArticleId IdType="pubmed">8959995</ArticleId></ArticleIdList></Reference><Reference><Citation>Fahnestock M, Shekari A (2019) ProNGF and neurodegeneration in Alzheimer&#x2019;s disease. Front Neurosci 13:129. https://doi.org/10.3389/fnins.2019.00129</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.00129</ArticleId><ArticleId IdType="pubmed">30853882</ArticleId><ArticleId IdType="pmc">6395390</ArticleId></ArticleIdList></Reference><Reference><Citation>Francardo V et al (2011) Impact of the lesion procedure on the profiles of motor impairment and molecular responsiveness to L-DOPA in the 6-hydroxydopamine mouse model of Parkinson&#x2019;s disease. Neurobiol Dis 42:327&#x2013;340. https://doi.org/10.1016/j.nbd.2011.01.024</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2011.01.024</ArticleId><ArticleId IdType="pubmed">21310234</ArticleId></ArticleIdList></Reference><Reference><Citation>Garbuzova-Davis S, Ehrhart J, Sanberg PR (2017) Cord blood as a potential therapeutic for amyotrophic lateral sclerosis. Expert Opin Biol Ther 17:837&#x2013;851. https://doi.org/10.1080/14712598.2017.1323862</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14712598.2017.1323862</ArticleId><ArticleId IdType="pubmed">28443372</ArticleId></ArticleIdList></Reference><Reference><Citation>Golpich M et al (2017) Mitochondrial dysfunction and biogenesis in neurodegenerative diseases: pathogenesis and treatment. CNS Neurosci Ther 23:5&#x2013;22. https://doi.org/10.1111/cns.12655</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cns.12655</ArticleId><ArticleId IdType="pubmed">27873462</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurney ME et al (1994) Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science 264:1772&#x2013;1775. https://doi.org/10.1126/science.8209258</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.8209258</ArticleId></ArticleIdList></Reference><Reference><Citation>Harmer NJ, Chirgadze D, Hyun Kim K, Pellegrini L, Blundell TL (2003) The structural biology of growth factor receptor activation. Biophys Chem 100:545&#x2013;553. https://doi.org/10.1016/s0301-4622(02)00305-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0301-4622(02)00305-8</ArticleId><ArticleId IdType="pubmed">12646390</ArticleId></ArticleIdList></Reference><Reference><Citation>Henriques A, Pitzer C, Schneider A (2010) Characterization of a novel SOD-1(G93A) transgenic mouse line with very decelerated disease development. PLoS ONE 5:e15445. https://doi.org/10.1371/journal.pone.0015445</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0015445</ArticleId><ArticleId IdType="pubmed">21102999</ArticleId><ArticleId IdType="pmc">2978730</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang EJ, Reichardt LF (2003) Trk receptors: roles in neuronal signal transduction. Annu Rev Biochem 72:609&#x2013;642. https://doi.org/10.1146/annurev.biochem.72.121801.161629</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.biochem.72.121801.161629</ArticleId><ArticleId IdType="pubmed">12676795</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaiswal MK (2019) Riluzole and edaravone: a tale of two amyotrophic lateral sclerosis drugs. Med Res Rev 39:733&#x2013;748. https://doi.org/10.1002/med.21528</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/med.21528</ArticleId><ArticleId IdType="pubmed">30101496</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaplan DR, Stephens RM (1994) Neurotrophin signal transduction by the Trk receptor. J Neurobiol 25:1404&#x2013;1417. https://doi.org/10.1002/neu.480251108</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/neu.480251108</ArticleId><ArticleId IdType="pubmed">7852994</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaur SJ, McKeown SR, Rashid S (2016) Mutant SOD1 mediated pathogenesis of amyotrophic lateral sclerosis. Gene 577:109&#x2013;118. https://doi.org/10.1016/j.gene.2015.11.049</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gene.2015.11.049</ArticleId><ArticleId IdType="pubmed">26657039</ArticleId></ArticleIdList></Reference><Reference><Citation>King AE, Woodhouse A, Kirkcaldie MT, Vickers JC (2016) Excitotoxicity in ALS: overstimulation, or overreaction? Exp Neurol 275:162&#x2013;171. https://doi.org/10.1016/j.expneurol.2015.09.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2015.09.019</ArticleId><ArticleId IdType="pubmed">26584004</ArticleId></ArticleIdList></Reference><Reference><Citation>Latina V, Caioli S, Zona C, Ciotti MT, Amadoro G, Calissano P (2017) Impaired NGF/TrkA signaling causes early AD-linked presynaptic dysfunction in cholinergic primary neurons. Front Cell Neurosci 11:68. https://doi.org/10.3389/fncel.2017.00068.eCollection2017</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2017.00068.eCollection2017</ArticleId><ArticleId IdType="pubmed">28360840</ArticleId><ArticleId IdType="pmc">5350152</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee R, Kermani P, Teng KK, Hempstead BL (2001) Regulation of cell survival by secreted proneurotrophins. Science 294:1945&#x2013;1948. https://doi.org/10.1126/science.1065057</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1065057</ArticleId><ArticleId IdType="pubmed">11729324</ArticleId></ArticleIdList></Reference><Reference><Citation>Lehigh KM, West KM, Ginty DD (2017) Retrogradely transported TrkA endosomes signal locally within dendrites to maintain sympathetic neuron synapses. Cell Rep 19:86&#x2013;100. https://doi.org/10.1016/j.celrep.2017.03.028</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2017.03.028</ArticleId><ArticleId IdType="pubmed">28380365</ArticleId><ArticleId IdType="pmc">5562950</ArticleId></ArticleIdList></Reference><Reference><Citation>Levi-Montalcini R (2004) The nerve growth factor and the neuroscience chess board. Prog Brain Res 146:525&#x2013;527</Citation><ArticleIdList><ArticleId IdType="pubmed">14699984</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J, Wang LN (2018) The efficacy and safety of riluzole for neurodegenerative movement disorders: a systematic review with meta-analysis. Drug Deliv 25:43&#x2013;48. https://doi.org/10.1080/10717544.2017.1413446</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10717544.2017.1413446</ArticleId><ArticleId IdType="pubmed">29226728</ArticleId></ArticleIdList></Reference><Reference><Citation>Ludolph AC, Brettschneider J, Weishaupt JH (2012) Amyotrophic lateral sclerosis. Curr Opin Neurol 25:530&#x2013;535. https://doi.org/10.1097/WCO.0b013e328356d328</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WCO.0b013e328356d328</ArticleId><ArticleId IdType="pubmed">22918486</ArticleId></ArticleIdList></Reference><Reference><Citation>Mavlyutov TA, Baker EM, Losenegger TM, Kim JR, Torres B, Epstein ML, Ruoho AE (2017) The sigma-1 receptor-A therapeutic target for the treatment of ALS? Adv Exp Med Biol 964:255&#x2013;265. https://doi.org/10.1007/978-3-319-50174-1_17</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-319-50174-1_17</ArticleId><ArticleId IdType="pubmed">28315276</ArticleId></ArticleIdList></Reference><Reference><Citation>McManus MJ, Franklin JL (2018) Dissociation of JNK activation from elevated levels of reactive oxygen species, cytochrome c release, and cell death in NGF-deprived sympathetic neurons. Mol Neurobiol 55:382&#x2013;389. https://doi.org/10.1007/s12035-016-0332-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-016-0332-2</ArticleId><ArticleId IdType="pubmed">27957682</ArticleId></ArticleIdList></Reference><Reference><Citation>Menon P, Kiernan MC, Vucic S (2014) Biomarkers and future targets for development in amyotrophic lateral sclerosis. Curr Med Chem 21:3535&#x2013;3550. https://doi.org/10.2174/0929867321666140601161148</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/0929867321666140601161148</ArticleId><ArticleId IdType="pubmed">24934359</ArticleId></ArticleIdList></Reference><Reference><Citation>Middleton G, Davies AM (2001) Populations of NGF-dependent neurones differ in their requirement for BAX to undergo apoptosis in the absence of NGF/TrkA signalling in vivo. Development 128:4715&#x2013;4728</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dev.128.23.4715</ArticleId></ArticleIdList></Reference><Reference><Citation>Minnone G, De Benedetti F, Bracci-Laudiero L (2017) NGF and its receptors in the regulation of inflammatory response. Int J Mol Sci. https://doi.org/10.3390/ijms18051028</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms18051028</ArticleId><ArticleId IdType="pubmed">28492466</ArticleId><ArticleId IdType="pmc">5454940</ArticleId></ArticleIdList></Reference><Reference><Citation>Mis MSC, Brajkovic S, Tafuri F, Bresolin N, Comi GP, Corti S (2017) Development of therapeutics for C9ORF72 ALS/FTD-related disorders. Mol Neurobiol 54:4466&#x2013;4476. https://doi.org/10.1007/s12035-016-9993-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-016-9993-0</ArticleId><ArticleId IdType="pubmed">27349438</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitsumoto H, Brooks BR, Silani V (2014) Clinical trials in amyotrophic lateral sclerosis: why so many negative trials and how can trials be improved? Lancet Neurol 13:1127&#x2013;1138. https://doi.org/10.1016/S1474-4422(14)70129-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(14)70129-2</ArticleId><ArticleId IdType="pubmed">25316019</ArticleId></ArticleIdList></Reference><Reference><Citation>Morgan S, Orrell RW (2016) Pathogenesis of amyotrophic lateral sclerosis. Br Med Bull 119:87&#x2013;98. https://doi.org/10.1093/bmb/ldw026</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bmb/ldw026</ArticleId><ArticleId IdType="pubmed">27450455</ArticleId></ArticleIdList></Reference><Reference><Citation>Oliveira SL, Trujillo CA, Negraes PD, Ulrich H (2015) Effects of ATP and NGF on proliferation and migration of neural precursor cells. Neurochem Res 40:1849&#x2013;1857. https://doi.org/10.1007/s11064-015-1674-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11064-015-1674-2</ArticleId><ArticleId IdType="pubmed">26233465</ArticleId></ArticleIdList></Reference><Reference><Citation>Oskarsson B, Gendron TF, Staff NP (2018) Amyotrophic lateral sclerosis: an update for 2018. Mayo Clin Proc 93:1617&#x2013;1628. https://doi.org/10.1016/j.mayocp.2018.04.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2018.04.007</ArticleId><ArticleId IdType="pubmed">30401437</ArticleId></ArticleIdList></Reference><Reference><Citation>Pandya RS et al (2012) Neuroprotection for amyotrophic lateral sclerosis: role of stem cells, growth factors, and gene therapy. Cent Nerv Syst Agents Med Chem 12:15&#x2013;27. https://doi.org/10.2174/187152412800229152</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/187152412800229152</ArticleId><ArticleId IdType="pubmed">22283698</ArticleId><ArticleId IdType="pmc">4170803</ArticleId></ArticleIdList></Reference><Reference><Citation>Patapoutian A, Reichardt LF (2001) Trk receptors: mediators of neurotrophin action. Curr Opin Neurobiol 11:272&#x2013;280. https://doi.org/10.1016/s0959-4388(00)00208-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0959-4388(00)00208-7</ArticleId><ArticleId IdType="pubmed">11399424</ArticleId></ArticleIdList></Reference><Reference><Citation>Pehar M et al (2004) Astrocytic production of nerve growth factor in motor neuron apoptosis: implications for amyotrophic lateral sclerosis. J Neurochem 89:464&#x2013;473. https://doi.org/10.1111/j.1471-4159.2004.02357.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2004.02357.x</ArticleId><ArticleId IdType="pubmed">15056289</ArticleId></ArticleIdList></Reference><Reference><Citation>Pepeu G, Grazia Giovannini M (2017) The fate of the brain cholinergic neurons in neurodegenerative diseases. Brain Res 1670:173&#x2013;184. https://doi.org/10.1016/j.brainres.2017.06.023</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2017.06.023</ArticleId><ArticleId IdType="pubmed">28652219</ArticleId></ArticleIdList></Reference><Reference><Citation>Petri S, K&#xf6;rner S, Kiaei M (2012) Nrf2/ARE signaling pathway: key mediator in oxidative stress and potential therapeutic target in ALS. Neurol Res Int 2012:878030. https://doi.org/10.1155/2012/878030</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2012/878030</ArticleId><ArticleId IdType="pubmed">23050144</ArticleId><ArticleId IdType="pmc">3461296</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrov D, Mansfield C, Moussy A, Hermine O (2017) ALS clinical trials review: 20 years of failure. Are we any closer to registering a new treatment? Front Aging Neurosci 9:68. https://doi.org/10.3389/fnagi.2017.00068</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2017.00068</ArticleId><ArticleId IdType="pubmed">28382000</ArticleId><ArticleId IdType="pmc">5360725</ArticleId></ArticleIdList></Reference><Reference><Citation>Rao SD, Yin HZ, Weiss JH (2003) Disruption of glial glutamate transport by reactive oxygen species produced in motor neurons. J Neurosci 23:2627&#x2013;2633</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.23-07-02627.2003</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen DR et al (1993) Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362:59&#x2013;62. https://doi.org/10.1038/362059a0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/362059a0</ArticleId><ArticleId IdType="pubmed">8446170</ArticleId><ArticleId IdType="pmc">8446170</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossi S, Cozzolino M, Carr&#xec; MT (2016) Old versus new mechanisms in the pathogenesis of ALS. Brain Pathol 26:276&#x2013;286. https://doi.org/10.1111/bpa.12355</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bpa.12355</ArticleId><ArticleId IdType="pubmed">26779612</ArticleId><ArticleId IdType="pmc">8029354</ArticleId></ArticleIdList></Reference><Reference><Citation>Saberi S, Stauffer JE, Schulte DJ, Ravits J (2015) Neuropathology of amyotrophic lateral sclerosis and its variants. Neurol Clin 33:855&#x2013;876. https://doi.org/10.1016/j.ncl.2015.07.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ncl.2015.07.012</ArticleId><ArticleId IdType="pubmed">26515626</ArticleId><ArticleId IdType="pmc">4628785</ArticleId></ArticleIdList></Reference><Reference><Citation>Salameh JS, Brown RH Jr, Berry JD (2015) Amyotrophic lateral sclerosis: review. Semin Neurol 35:469&#x2013;476. https://doi.org/10.1055/s-0035-1558984</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0035-1558984</ArticleId><ArticleId IdType="pubmed">26502769</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanes DH, Thomas AR, Harris WA (2011) Naturally-occurring neuron death. Development of the nervous system, 3rd edn. Academic Press, Boston, pp 171&#x2013;208</Citation></Reference><Reference><Citation>Shi P, Gal J, Kwinter DM, Liu X, Zhu H (2010) Mitochondrial dysfunction in amyotrophic lateral sclerosis. Biochim Biophys Acta 1802:45&#x2013;51. https://doi.org/10.1016/j.bbadis.2009.08.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2009.08.012</ArticleId><ArticleId IdType="pubmed">19715760</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith EF, Shaw PJ, De Vos KJ (2019) The role of mitochondria in amyotrophic lateral sclerosis. Neurosci Lett 710:132933. https://doi.org/10.1016/j.neulet.2017.06.052</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2017.06.052</ArticleId><ArticleId IdType="pubmed">28669745</ArticleId></ArticleIdList></Reference><Reference><Citation>Tefera TW, Borges K (2017) Metabolic dysfunctions in amyotrophic lateral sclerosis pathogenesis and potential metabolic treatments. Front Neurosci 10:611. https://doi.org/10.3389/fnins.2016.00611</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2016.00611</ArticleId><ArticleId IdType="pubmed">28119559</ArticleId><ArticleId IdType="pmc">5222822</ArticleId></ArticleIdList></Reference><Reference><Citation>White JA, Banerjee R, Gunawardena S (2016) Axonal transport and neurodegeneration: how marine drugs can be used for the development of therapeutics. Mar Drugs. https://doi.org/10.3390/md14050102</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/md14050102</ArticleId><ArticleId IdType="pubmed">27213408</ArticleId><ArticleId IdType="pmc">4882576</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong AW, Yeung KPJ, Payne SC, Keast JR, Osborne PB (2015) Neurite outgrowth in normal and injured primary sensory neurons reveals different regulation by nerve growth factor (NGF) and artemin. Mol Cell Neurosci 65:125&#x2013;134. https://doi.org/10.1016/j.mcn.2015.03.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcn.2015.03.004</ArticleId><ArticleId IdType="pubmed">25752731</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia B, Lv Y (2017) Dual-delivery of VEGF and NGF by emulsion electrospun nanofibrous scaffold for peripheral nerve regeneration. Brain Res 1670:173&#x2013;184. https://doi.org/10.1016/j.msec.2017.08.030</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.msec.2017.08.030</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshino H (2019) Edaravone for the treatment of amyotrophic lateral sclerosis. Expert Rev Neurother 27:1&#x2013;9. https://doi.org/10.1080/14737175.2019.1581610</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14737175.2019.1581610</ArticleId></ArticleIdList></Reference><Reference><Citation>Zarate CA, Manji HK (2008) Riluzole in psychiatry: a systematic review of the literature. Expert Opin Drug Metab Toxicol 4:1223&#x2013;1234. https://doi.org/10.1517/17425255.4.9.1223</Citation><ArticleIdList><ArticleId IdType="doi">10.1517/17425255.4.9.1223</ArticleId><ArticleId IdType="pubmed">18721116</ArticleId><ArticleId IdType="pmc">2587133</ArticleId></ArticleIdList></Reference><Reference><Citation>Zarei S et al (2015) A comprehensive review of amyotrophic lateral sclerosis. Surg Neurol Int 6:171. https://doi.org/10.4103/2152-7806.169561</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/2152-7806.169561</ArticleId><ArticleId IdType="pubmed">26629397</ArticleId><ArticleId IdType="pmc">4653353</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhong SJ, Gong YH, Lin YC (2017) Combined intranasal nerve growth factor and ventricle neural stem cell grafts prolong survival and improve disease outcome in amyotrophic lateral sclerosis transgenic mice. Neurosci Lett 656:1&#x2013;8. https://doi.org/10.1016/j.neulet.2017.07.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2017.07.005</ArticleId><ArticleId IdType="pubmed">28694091</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y et al (2015) An astrocyte regenerative response from vimentin-containing cells in the spinal cord of amyotrophic lateral sclerosis&#x2019;s disease-like transgenic (G93A SOD1) mice. Neurodegener Dis 15:1&#x2013;12. https://doi.org/10.1159/000369466</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000369466</ArticleId><ArticleId IdType="pubmed">25591625</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo E et al (2019) 2,5-Hexanedione mediates neuronal apoptosis through suppression of NGF via PI3K/Akt signaling in the rat sciatic nerve. Biosci Rep. https://doi.org/10.1042/BSR20181122</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BSR20181122</ArticleId><ArticleId IdType="pubmed">31710083</ArticleId><ArticleId IdType="pmc">6900473</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>